COLLEEN LANE: Open Payments
NPI 1326689753 · ERDENHEIM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,161 in 55 payments from 11 companies in 2025. Trend: 2023 $643 · 2024 $1,064 · 2025 $1,161
Food & beverage: $1,161
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $419 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $230 |
| Otsuka America Pharmaceutical, Inc. | 13 | $144 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| Collegium Pharmaceutical, Inc. | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| Alkermes, Inc. | 1 | $32 |
| Boston Scientific Corporation | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Auvelity, Jornay PM, FANAPT, ARISTADA, WaveWriter Alpha Prime 16.
Industry payments across PA — which companies pay providers there.
